LICENSEAPPROVED

Michigan State University Awards License Contract to SYMBIOCI (June 2026)

Michigan State University approved an exclusive license agreement with SymbioCI for a Wolbachia-based mosquito technology to control dengue. Compensation includes a 4–8% equity stake, 1–3% running royalties, escalating minimum payments from 2028, and a share of sublicense revenues.

Status
APPROVED
Document date
June 12, 2026
Contract type
LICENSE
Vendor
SYMBIOCI
Agency
Michigan State University · MI

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Scope & details

The full contract record, as filed.

Contract amount
4-8% equity stake; running royalties of 1-3%; escalating annual minimum payments $500–$20,000/year starting in CY2028; share of non-royalty sublicense revenue on a 75%–10% sliding scale
Contract type
LICENSE
Contract term
From the date of last signature (on or after January 4, 2027) until termination by either party
Renewal
Agreement runs from final signature date (on or after January 4, 2027) until terminated by either party; no fixed expiration date outside termination provisions.
Document type
AgendaPacket
Source document
Michigan State University Board of Trustees Audit, Risk & Compliance Committee Agenda Packet 2026-06-12

Related contracts

Other contracts from SYMBIOCI.

View all →

Frequently asked questions

Common questions about this contract, answered from the record.

Who was awarded the license contract by Michigan State University?

SYMBIOCI was awarded this license contract by Michigan State University, as recorded on June 12, 2026. The contract value is 4-8% equity stake; running royalties of 1-3%; escalating annual minimum payments $500–$20,000/year starting in CY2028; share of non-royalty sublicense revenue on a 75%–10% sliding scale.

How much is the SYMBIOCI contract with Michigan State University worth?

The SYMBIOCI contract with Michigan State University is valued at 4-8% equity stake; running royalties of 1-3%; escalating annual minimum payments $500–$20,000/year starting in CY2028; share of non-royalty sublicense revenue on a 75%–10% sliding scale, covering license work.

What type of contract is this?

This is a License contract, documented as a agendapacket record.

Where was this contract approved?

This contract appears in Michigan State University Board of Trustees Audit, Risk & Compliance Committee Agenda Packet 2026-06-12 (AgendaPacket), dated June 12, 2026 from Michigan State University. Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What other contracts does SYMBIOCI hold?

SYMBIOCI may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

View SYMBIOCI's profile

What is Michigan State University currently buying?

Explore Michigan State University's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

View Michigan State University's profile

Bring us your territory.
We'll show you what is forming.

B2G and SLED sales intelligence. Surface government procurement signals from 80,000+ state, local, and education agencies months before the RFP.

Try Civic IQ for free